home about animi-3 Skip Navigation Links
deficienciesExpand deficiencies
healthcare professionals research contact
 
Arthritis
Cardiovascular
Depression
Diabetes
Pregnancy
Alcohol Consumption


Cardiovascular

Omega-3
“Our prospective study provides evidence for the beneficial effects of fish and omega-3 fatty acid consumption on the risk of CHD and total mortality among diabetic women.” *
Hu, F.B. Cardiology Review 2004;21:32-35. 

B Vitamins
“...plasma homocysteine can be reliably lowered 25 to 30 percent with a daily dose of at least 500 micrograms of folic acid in combination with vitamin B12 and [B6]...” **
Schnyder, G., et al. N Engl J Med 2001;345:1593-1600.


Peer-Reviewed Studies

Omega-3 Fatty Acids

B Vitamins

 

----------------------------------------------------------
*FDA “Qualified Health Claims” Omega-3 Fatty Acids & Coronary Heart Disease. Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the above claim and determined that, although there is scientific evidence supporting the claim, the evidence is not conclusive. Docket No. 9IN-0103.
** FDA “Qualified Health Claims” B vitamins & Vascular Disease. As part of a well-balanced diet that is low in saturated fat and cholesterol, Folic Acid, Vitamin B6 and Vitamin B12 may reduce the risk of vascular disease. FDA evaluated the above claim and found that, while it is known that diets low in saturated fat and cholesterol reduce the risk of heart disease and other vascular diseases, the evidence in support of the above claim is inconclusive. Docket No. 99P-3029.
1 Maradit-Kremers, H., et al. Increased Unrecognized Coronary Heart Disease and Sudden Deaths in Rheumatoid Arthritis. Arth & Rheum 2005;52(2):402-11.

 
Prescribing Info Side Effects Free Voucher Availability Press Room PBM Pharmaceuticals


Animi-3 is indicated for improving nutritional status in conditions requiring DHA, Vitamin B12, B6, and folic acid supplementation.
Animi-3 is not intended to diagnose, treat, or cure any disease.